These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24618180)

  • 21. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
    Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of potential colorectal cancer serum biomarkers through quantitative proteomics on the colonic tissue interstitial fluids from the AOM-DSS mouse model.
    Wang Y; Shan Q; Hou G; Zhang J; Bai J; Lv X; Xie Y; Zhu H; Su S; Li Y; Zi J; Lin L; Han W; Zhao X; Wang H; Xu N; Wu L; Lou X; Liu S
    J Proteomics; 2016 Jan; 132():31-40. PubMed ID: 26581642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selected reaction monitoring for colorectal cancer diagnosis using a set of five serum peptides identified by BLOTCHIP
    Uchiyama K; Naito Y; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Nonaka D; Asada K; Lee LJ; Tanaka K; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y
    J Gastroenterol; 2018 Nov; 53(11):1179-1185. PubMed ID: 29497816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations in SELDI-TOF MS whole serum proteomic profiling with IMAC surface to specifically detect colorectal cancer.
    Wang Q; Shen J; Li ZF; Jie JZ; Wang WY; Wang J; Zhang ZT; Li ZX; Yan L; Gu J
    BMC Cancer; 2009 Aug; 9():287. PubMed ID: 19689818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum proteomic profiling for the early diagnosis of colorectal cancer.
    Zhu D; Wang J; Ren L; Li Y; Xu B; Wei Y; Zhong Y; Yu X; Zhai S; Xu J; Qin X
    J Cell Biochem; 2013 Feb; 114(2):448-55. PubMed ID: 22961748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population.
    Chen YD; Zheng S; Yu JK; Hu X
    Clin Cancer Res; 2004 Dec; 10(24):8380-5. PubMed ID: 15623616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.
    Duan B; Bai J; Qiu J; Wang J; Tong C; Wang X; Miao J; Li Z; Li W; Yang J; Huang C
    EBioMedicine; 2018 Nov; 37():134-143. PubMed ID: 30361067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry.
    Jones JJ; Wilcox BE; Benz RW; Babbar N; Boragine G; Burrell T; Christie EB; Croner LJ; Cun P; Dillon R; Kairs SN; Kao A; Preston R; Schreckengaust SR; Skor H; Smith WF; You J; Hillis WD; Agus DB; Blume JE
    Clin Colorectal Cancer; 2016 Jun; 15(2):186-194.e13. PubMed ID: 27237338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer.
    Albrethsen J; Bøgebo R; Møller CH; Olsen JA; Raskov HH; Gammeltoft S
    Proteomics Clin Appl; 2012 Apr; 6(3-4):182-9. PubMed ID: 22532454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic identification of alpha-2-HS-glycoprotein as a plasma biomarker of hypopharyngeal squamous cell carcinoma.
    Tian WD; Li JZ; Hu SW; Peng XW; Li G; Liu X; Chen HH; Xu X; Li XP
    Int J Clin Exp Pathol; 2015; 8(8):9021-31. PubMed ID: 26464644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered Serum Annexin A2 Might Be a New Potential Diagnostic Biomarker in Human Colorectal Cancer.
    Hu D; Shen B; Yu M; Zha X; Zhou Y; Chen F; Ren J; Zhang L
    Ann Clin Lab Sci; 2020 Nov; 50(6):726-733. PubMed ID: 33334786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revelation of Proteomic Indicators for Colorectal Cancer in Initial Stages of Development.
    Kopylov AT; Stepanov AA; Malsagova KA; Soni D; Kushlinsky NE; Enikeev DV; Potoldykova NV; Lisitsa AV; Kaysheva AL
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32023884
    [No Abstract]   [Full Text] [Related]  

  • 37. Case-controlled identification of colorectal cancer based on proteomic profiles and the potential for screening.
    Huijbers A; Mesker WE; Mertens BJ; Bladergroen MR; Deelder AM; van der Burgt YE; Tollenaar RA
    Colorectal Dis; 2014 Nov; 16(11):907-13. PubMed ID: 25243779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.